DrugDashboards

Doryx Mpc

doxycycline hyclate · DOXYCYCLINE HYCLATE 60 mg/1 · Tablet, Delayed Release · Oral · Mayne Pharma Commercial LLC

NDC 51862-0560-60 · 60 TABLET, DELAYED RELEASE in 1 BOTTLE · NDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $18.18 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$18.18per EAinvoice-surveyed acquisition cost · Dec 17, 2025
  • Part D plans paid (avg)$19.26per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$13.56per unitMayne Pharma Commercial LLC · Jan 1, 202675% of what pharmacies pay — a deeper discount than 67% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$10.00$20.00Jul 2024Dec 2025$18.18
7 price points · per EA · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

#30 count
$545.47
#90 count
$1636.40

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$614,005
589 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for doxycycline hyclate (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $999.18 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA050795
TE code
—
Approval date
May 6, 2005
Patents / exclusivity
14 patents, 0 exclusivities
TypeNumber / codeExpires
patent9446057Dec 23, 2034
patent9446057Dec 23, 2034
patent9511031Oct 23, 2034
patent9295652Oct 23, 2034
patent9295652Oct 23, 2034
patent9511031Oct 23, 2034
patent8715724Feb 3, 2028
patent8715724Feb 3, 2028
patent8715724Feb 3, 2028
patent8715724Feb 3, 2028
patent8715724Feb 3, 2028
patent8715724Feb 3, 2028

Shortage history

  • Planned discontinuation — Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60)Jul 30, 2026
  • Planned discontinuation — Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22)Jul 30, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of doxycycline hyclate (Tablet, Delayed Release)

LabelerStrengthFirst seenLast seen
Actavis Pharma, Inc.DOXYCYCLINE HYCLATE 200 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DOXYCYCLINE HYCLATE 50 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DOXYCYCLINE HYCLATE 100 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DOXYCYCLINE HYCLATE 200 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DOXYCYCLINE HYCLATE 150 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DOXYCYCLINE HYCLATE 75 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDOXYCYCLINE HYCLATE 200 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDOXYCYCLINE HYCLATE 100 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDOXYCYCLINE HYCLATE 150 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDOXYCYCLINE HYCLATE 75 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.DOXYCYCLINE HYCLATE 200 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.DOXYCYCLINE HYCLATE 100 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.DOXYCYCLINE HYCLATE 75 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.DOXYCYCLINE HYCLATE 150 mg/1Jul 15, 2026Sep 2, 2026
Mayne Pharma Commercial LLCDOXYCYCLINE HYCLATE 60 mg/1Jul 15, 2026Sep 2, 2026
Mayne Pharma Commercial LLCDOXYCYCLINE HYCLATE 200 mg/1Jul 15, 2026Sep 2, 2026
Mayne Pharma International Pty Ltd.DOXYCYCLINE HYCLATE 60 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US LLCDOXYCYCLINE HYCLATE 150 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US LLCDOXYCYCLINE HYCLATE 200 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US LLCDOXYCYCLINE HYCLATE 50 mg/1Jul 15, 2026Sep 2, 2026
Sonoma Pharmaceuticals, Inc.DOXYCYCLINE HYCLATE 150 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Doryx Mpc — NDC 51862-0560-60," retrieved September 3, 2026, https://drugdashboards.com/drug/51862056060.

Free to cite with attribution — see how the data is put together.